Continuous Glucose Monitoring in Type 2 Diabetes: Access, Outcomes, and Cost-effectiveness
Personalized briefing
Discovery of the day · Diabetes
The most significant scientific discovery today
Dear Dr. Vijay Viswanathan, this is your personalized scientific intelligence briefing — curated for your work in Diabetes.
Key finding
Medicine · Diabetes
Discovery of the day
Continuous Glucose Monitoring in Type 2 Diabetes: Clinical Outcomes, Disparities in Access, and Cost-effectiveness
This comprehensive review synthesizes current evidence on continuous glucose monitoring (CGM) in type 2 diabetes, examining its clinical outcomes, persistent disparities in patient access, and overall cost-effectiveness. The analysis demonstrates that CGM consistently improves glycemic control across diverse patient populations, yet significant barriers remain—particularly for under-resourced communities and developing healthcare systems. For a specialist leading diabetes care in India, these findings underscore the urgent need to develop scalable, cost-effective CGM implementation strategies that can bridge the access gap and improve outcomes for the millions of type 2 diabetes patients in the region.
Novelty
76%
Rigor
85%
Significance
91%
Validity
82%
Clarity
88%
Advertisement
Source lab and medical equipment directly from China — verified suppliers, no middlemen
ScientificChina connects research institutions and procurement teams with trusted Chinese manufacturers of lab instruments, medical devices, and scientific equipment — at a fraction of Western market prices.
Update your briefing preferences →
Science Briefing is published by Fountain of Science LLC, Miami, FL.
Your briefing is personalized based on your selected fields, keywords, and research interests.
